← Open Payments lookup

KYLE MANSCUK: Open Payments

NPI 1104313519 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$457 in 22 payments from 13 companies in 2025. Trend: 2023 $996 · 2024 $796 · 2025 $457

Food & beverage: $457
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation6$118
EMD Serono, Inc.3$59
Eisai Inc.2$49
Gilead Sciences, Inc.2$35
GENZYME CORPORATION1$30
TAIHO ONCOLOGY, INC.1$27
AstraZeneca Pharmaceuticals LP1$26
Janssen Biotech, Inc.1$23
E.R. Squibb & Sons, L.L.C.1$21
Astellas Pharma US Inc1$20

Products named: Fabhalta, KISQALI, Lenvima, Trodelvy, SARCLISA, LONSURF, ENHERTU, RYBREVANT.

Industry payments across FL — which companies pay providers there.